The Vaccine Research Center at the Finnish Tampere University is selecting children from 6 months to 12 years old for testing the coronavirus vaccine, Report informs referring to foreign media.
The scientific project was developed and sponsored by Pfizer and is being carried out in addition to Finland in Spain, Poland, and the US.
“The research is open to healthy children under 12 years of age who don’t have an immune-lowering disease, multisystem inflammation syndrome in children and adolescents (MIS-C) or an allergic reaction to vaccines,” the report said.
The groups of children from two years and older have already been fully recruited, and now researchers are looking for babies aged 6 to 24 months - about 1,250 in total.
After the study, the use of the drug must be approved by the regulatory body of the EU - the European Medicines Agency. Vaccination of this population group may begin as early as next year.
Coronavirus vaccination for adolescents 12 years and older began in Finland in August.